Bosentan for treatment of inoperable chronic thromboembolic pulmonary hypertension: BENEFiT (Bosentan Effects in iNopErable Forms of chronIc Thromboembolic pulmonary hypertension), a randomized, placebo-controlled trial.
暂无分享,去创建一个
A. Torbicki | H. Ghofrani | X. Jaïs | G. Simonneau | M. Hoeper | L. Rubin | I. Lang | M. Delcroix | E. Mayer | A. D'armini | P. Jansa | L. Perchenet | A. Morganti | J. Pepke‐Zaba | J. Pepke-Zaba